Literature DB >> 24090919

Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents.

Pablo D Elicio1, María N Chao, Melina Galizzi, Catherine Li, Sergio H Szajnman, Roberto Docampo, Silvia N J Moreno, Juan B Rodriguez.   

Abstract

As a part of our project pointed at the search of new safe chemotherapeutic and chemoprophylactic agents against parasitic diseases, several compounds structurally related to 4-phenoxyphenoxyethyl thiocyanate (WC-9), which were modified at the terminal aromatic ring, were designed, synthesized and evaluated as antiproliferative agents against Trypanosoma cruzi, the parasite responsible of American trypanosomiasis (Chagas disease) and Toxoplasma gondii, the etiological agent of toxoplasmosis. Most of the synthetic analogs exhibited similar antiparasitic activity being slightly more potent than the reference compound WC-9. For example, the nitro derivative 13 showed an ED₅₀ value of 5.2 μM. Interestingly, the regioisomer of WC-9, compound 36 showed similar inhibitory action than WC-9 indicating that para-phenyl substitution pattern is not necessarily required for biological activity. The biological evaluation against T. gondii was also very promising. The ED₅₀ values corresponding for 13, 36 and 37 were at the very low micromolar level against tachyzoites of T. gondii.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antiparasitic agents; Chagas disease; Squalene synthase inhibitors; Toxoplasma gondii; Toxoplasmosis; Trypanosoma cruzi; WC-9 analogs

Mesh:

Substances:

Year:  2013        PMID: 24090919      PMCID: PMC3831659          DOI: 10.1016/j.ejmech.2013.09.009

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  43 in total

1.  Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation.

Authors:  S H Szajnman; W Yan; B N Bailey; R Docampo; E Elhalem; J B Rodriguez
Journal:  J Med Chem       Date:  2000-05-04       Impact factor: 7.446

Review 2.  New antibacterials for the treatment of toxoplasmosis; a patent review.

Authors:  Juan Bautista Rodriguez; Sergio Hernán Szajnman
Journal:  Expert Opin Ther Pat       Date:  2012-03-10       Impact factor: 6.674

3.  Genetic evidence that an endosymbiont-derived endoplasmic reticulum-associated protein degradation (ERAD) system functions in import of apicoplast proteins.

Authors:  Swati Agrawal; Giel G van Dooren; Wandy L Beatty; Boris Striepen
Journal:  J Biol Chem       Date:  2009-10-06       Impact factor: 5.157

Review 4.  Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites.

Authors:  J A Urbina
Journal:  Parasitology       Date:  1997       Impact factor: 3.234

5.  Design, synthesis, and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes).

Authors:  A J Schvartzapel; L Zhong; R Docampo; J B Rodriguez; E G Gros
Journal:  J Med Chem       Date:  1997-07-18       Impact factor: 7.446

6.  Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors.

Authors:  G R Brown; D S Clarke; A J Foubister; S Freeman; P J Harrison; M C Johnson; K B Mallion; J McCormick; F McTaggart; A C Reid; G J Smith; M J Taylor
Journal:  J Med Chem       Date:  1996-07-19       Impact factor: 7.446

7.  Head-to-head prenyl tranferases: anti-infective drug targets.

Authors:  Fu-Yang Lin; Yi-Liang Liu; Kai Li; Rong Cao; Wei Zhu; Jordan Axelson; Ran Pang; Eric Oldfield
Journal:  J Med Chem       Date:  2012-05-01       Impact factor: 7.446

8.  Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.

Authors:  Kovi Bessoff; Adam Sateriale; K Kyungae Lee; Christopher D Huston
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

9.  Recombinant squalene synthase. Synthesis of non-head-to-tail isoprenoids in the absence of NADPH.

Authors:  Michael B Jarstfer; Dong-Lu Zhang; C Dale Poulter
Journal:  J Am Chem Soc       Date:  2002-07-31       Impact factor: 15.419

10.  Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition.

Authors:  I Coppens; A P Sinai; K A Joiner
Journal:  J Cell Biol       Date:  2000-04-03       Impact factor: 10.539

View more
  4 in total

1.  In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites.

Authors:  Sergio H Szajnman; Tamila Galaka; Zhu-Hong Li; Catherine Li; Nathan M Howell; María N Chao; Boris Striepen; Vasant Muralidharan; Silvia N J Moreno; Juan B Rodriguez
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

2.  Activity of Fluorine-Containing Analogues of WC-9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii.

Authors:  María N Chao; Catherine Li; Melissa Storey; Bruno N Falcone; Sergio H Szajnman; Sergio M Bonesi; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  ChemMedChem       Date:  2016-11-25       Impact factor: 3.466

3.  Aryloxyethyl Thiocyanates Are Potent Growth Inhibitors of Trypanosoma cruzi and Toxoplasma gondii.

Authors:  María N Chao; Carolina Exeni Matiuzzi; Melissa Storey; Catherine Li; Sergio H Szajnman; Roberto Docampo; Silvia N J Moreno; Juan B Rodriguez
Journal:  ChemMedChem       Date:  2015-04-27       Impact factor: 3.466

Review 4.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.